Zydus receives EIR report for manufacturing facility at Pharma SEZ in Ahmedabad
From USFDA
Zydus Cadila's Formulations Manufacturing Facility at Pharma SEZ, Ahmedabad has received an Establishment Inspection Report from the USFDA signifying the successful closure of the audit. The manufacturing plant had completed the USFDA audit from 16 to 24 January 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 29 2017 | 11:58 AM IST